NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Ipsen
Zev A Wainberg; Davide Melisi; Teresa Macarulla; Roberto Pazo Cid; Sreenivasa R Chandana; Christelle De La Fouchardière; Andrew Dean; Igor Kiss; Woo Jin Lee; Thorsten O Goetze; Eric Van Cutsem; A Scott Paulson; Tanios Bekaii-Saab; Shubham Pant; Richard A Hubner; Zhimin Xiao; Huanyu Chen; Fawzi Benzaghou; Eileen M O'Reilly